BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Chandra Diwakarla, Katherine Hannan, Nadine Hein, Desmond Yip. Advanced pancreatic ductal adenocarcinoma - Complexities of treatment and emerging therapeutic optionsWorld Journal of Gastroenterology 2017; 23(13): 2276-2285 doi: 10.3748/wjg.v23.i13.2276
2
Yumi Kim, Kang-Hoon Kim, In-Seung Lee, Ji Young Park, Yun-Cheol Na, Won-Seok Chung, Hyeung-Jin Jang. Apoptosis and G2/M cell cycle arrest induced by a timosaponin A3 from Anemarrhena asphodeloides Bunge on AsPC-1 pancreatic cancer cellsPhytomedicine 2019; 56: 48 doi: 10.1016/j.phymed.2018.08.006
3
Sharavan Ramachandran, Sanjay K. Srivastava. Repurposing Pimavanserin, an Anti-Parkinson Drug for Pancreatic Cancer TherapyMolecular Therapy - Oncolytics 2020; 19: 19 doi: 10.1016/j.omto.2020.08.019
4
Xifeng Xu, Qiong Wu, Zhen Wang, Song Zheng, Ke Ge, Changku Jia. Meta-analysis of FOLFIRINOX regimen as the first-line chemotherapy for locally advanced pancreatic cancer and borderline resectable pancreatic cancerClinical and Experimental Medicine 2019; 19(1): 149 doi: 10.1007/s10238-018-0540-3
5
Oliver A. Kent, Maria-Jose Sandi, Robert Rottapel. Co-dependency between KRAS addiction and ARHGEF2 promotes an adaptive escape from MAPK pathway inhibitionSmall GTPases 2019; 10(6): 441 doi: 10.1080/21541248.2017.1337545
6
Steven N. Hochwald, William G. Cance, Elena Kurenova. Encyclopedia of Cancer2014; : 3421 doi: 10.1007/978-3-662-46875-3_4358
7
Federica Eduati, Patricia Jaaks, Jessica Wappler, Thorsten Cramer, Christoph A Merten, Mathew J Garnett, Julio Saez‐Rodriguez. Patient‐specific logic models of signaling pathways from screenings on cancer biopsies to prioritize personalized combination therapiesMolecular Systems Biology 2020; 16(2) doi: 10.15252/msb.20188664
8
Mehdi El Amrani, François Corfiotti, Matthieu Corvaisier, Romain Vasseur, Maxence Fulbert, Cécile Skrzypczyk, Anne‐Claire Deshorgues, Viviane Gnemmi, David Tulasne, Fatima Lahdaoui, Audrey Vincent, François‐René Pruvot, Isabelle Seuningen, Guillemette Huet, Stéphanie Truant. Gemcitabine‐induced epithelial‐mesenchymal transition‐like changes sustain chemoresistance of pancreatic cancer cells of mesenchymal‐like phenotypeMolecular Carcinogenesis 2019; 58(11): 1985 doi: 10.1002/mc.23090
9
Jiangang Zhao, Jiahui Li, Hans A. Schlößer, Felix Popp, Marie Christine Popp, Hakan Alakus, Karl-Walter Jauch, Christiane J. Bruns, Yue Zhao. Targeting Cancer Stem Cells and Their Niche: Current Therapeutic Implications and Challenges in Pancreatic CancerStem Cells International 2017; 2017: 1 doi: 10.1155/2017/6012810
10
E. A. Bykova, N. A. Falaleeva, L. Yu. Grivtsova. PANCREATIC CANCER, CURRENT THERAPEUTIC APPROACHES AND POSSIBLE PROSPECTSRussian Journal of Biotherapy 2020; 19(4): 18 doi: 10.17650/1726-9784-2020-19-4-18-28
11
Xiaochen Wu, Qiqi Li, Fan Zhang, Lijun Wang, Jun Wang, Junting Fan, Guohu Di, Chuanlong Guo. Novel poly (ADP-ribose) polymerases inhibitor DHC-1 exhibits in vitro and in vivo anticancer activity on BRCA-deficient pancreatic cancer cellsFood and Chemical Toxicology 2021; 147: 111892 doi: 10.1016/j.fct.2020.111892
12
Han-xiang Zhan, Bin Zhou, Yu-gang Cheng, Jian-wei Xu, Lei Wang, Guang-yong Zhang, San-yuan Hu. Crosstalk between stromal cells and cancer cells in pancreatic cancer: New insights into stromal biologyCancer Letters 2017; 392: 83 doi: 10.1016/j.canlet.2017.01.041
13
Bhaskar Venkata Kameswara Subrahmanya Lakkakula, Batoul Farran, Saikrishna Lakkakula, Sujatha Peela, Nagendra Sastry Yarla, Pallaval Veera Bramhachari, Mohammad Amjad Kamal, Madhu Sudhana Saddala, Ganji Purnachandra Nagaraju. Small molecule tyrosine kinase inhibitors and pancreatic cancer—Trials and troublesSeminars in Cancer Biology 2019; 56: 149 doi: 10.1016/j.semcancer.2018.09.011
14
Maud-Emmanuelle Gilles, Federica Maione, Mélissande Cossutta, Gilles Carpentier, Laure Caruana, Silvia Di Maria, Claire Houppe, Damien Destouches, Ksenya Shchors, Christopher Prochasson, Fabien Mongelard, Simona Lamba, Alberto Bardelli, Philippe Bouvet, Anne Couvelard, José Courty, Enrico Giraudo, Ilaria Cascone. Nucleolin Targeting Impairs the Progression of Pancreatic Cancer and Promotes the Normalization of Tumor VasculatureCancer Research 2016; 76(24): 7181 doi: 10.1158/0008-5472.CAN-16-0300
15
Allison Solanki, Diana King, Guillaume Thibault, Lei Wang, Summer L. Gibbs, Irina V. Lebedeva. Quantification of fluorophore distribution and therapeutic response in matched in vivo and ex vivo pancreatic cancer model systemsPLOS ONE 2020; 15(2): e0229407 doi: 10.1371/journal.pone.0229407
16
Elzbieta Nowara, Joanna Huszno. Masitinib plus gemcitabine for personalized treatment of PDAC patients with overexpression of ACOX1Expert Review of Precision Medicine and Drug Development 2016; 1(6): 479 doi: 10.1080/23808993.2016.1257911
17
Rosalba Florio, Serena Veschi, Viviana di Giacomo, Sara Pagotto, Simone Carradori, Fabio Verginelli, Roberto Cirilli, Adriano Casulli, Antonino Grassadonia, Nicola Tinari, Amelia Cataldi, Rosa Amoroso, Alessandro Cama, Laura De Lellis. The Benzimidazole-Based Anthelmintic Parbendazole: A Repurposed Drug Candidate That Synergizes with Gemcitabine in Pancreatic CancerCancers 2019; 11(12): 2042 doi: 10.3390/cancers11122042
18
JingJing Duan, Wen Yue, JianYu E, Jyoti Malhotra, Shou-en Lu, Jun Gu, Feng Xu, Xiang-Lin Tan. In vitro comparative studies of resveratrol and triacetylresveratrol on cell proliferation, apoptosis, and STAT3 and NFκB signaling in pancreatic cancer cellsScientific Reports 2016; 6(1) doi: 10.1038/srep31672
19
Steven N. Hochwald, William G. Cance, Elena Kurenova. Encyclopedia of Cancer2014; : 1 doi: 10.1007/978-3-642-27841-9_4358-4
20
Taishi Higashi, Tetsuya Kogo, Nana Sato, Tatsunori Hirotsu, Shogo Misumi, Hideaki Nakamura, Daisuke Iohara, Risako Onodera, Keiichi Motoyama, Hidetoshi Arima. Efficient Anticancer Drug Delivery for Pancreatic Cancer Treatment Utilizing Supramolecular Polyethylene-Glycosylated BromelainACS Applied Bio Materials 2020; 3(5): 3005 doi: 10.1021/acsabm.0c00070
21
Matthew Loft, Belinda Lee, Jeanne Tie, Peter Gibbs. Clinical Applications of Circulating Tumour DNA in Pancreatic AdenocarcinomaJournal of Personalized Medicine 2019; 9(3): 37 doi: 10.3390/jpm9030037
22
Lijun Wang, Shuhong Zhang, Xuemin Yu, Chuanlong Guo. Novel Poly(ADP-ribose) Polymerase-1 Inhibitor DDHCB Inhibits Proliferation of BRCA Mutant Breast Cancer Cell In Vitro and In Vivo through a Synthetic Lethal MechanismChemical Research in Toxicology 2020; 33(7): 1874 doi: 10.1021/acs.chemrestox.0c00087
23
Bayarmaa Mandzhieva, Rima Shobar, Anum Jalil, Hammad Zafar, Mamoon Ur Rashid, Ranjeet Kumar, Akash Khetpal, Sarfraz Ahmad. Phytochemicals Targeting Tumor Microenvironment in Gastrointestinal Cancers2020; : 223 doi: 10.1007/978-3-030-48405-7_11
24
Wei Hu, Xuefeng Jia, Yanfang Gao, Qiujie Zhang. Chaetospirolactone reverses the apoptotic resistance towards TRAIL in pancreatic cancerBiochemical and Biophysical Research Communications 2018; 495(1): 621 doi: 10.1016/j.bbrc.2017.10.144
25
Seyoung Park, Hao Xu, Hongyu Zhao. Integrating Multidimensional Data for Clustering Analysis With Applications to Cancer Patient DataJournal of the American Statistical Association 2020; : 1 doi: 10.1080/01621459.2020.1730853
26
Dinesh Kumar, Pranjal Sarma, Manika P. Bhadra, Anjana D. Tangutur. Impact of Hybrid-polar Histone Deacetylase Inhibitor m-Carboxycinnamic Acid bis-Hydroxyamide on Human Pancreatic Adenocarcinoma CellsAnti-Cancer Agents in Medicinal Chemistry 2019; 19(6): 750 doi: 10.2174/1871520619666190101115034
27
鹏 闫. Advances in Diagnosis and Treatment of Pancreatic CancerHans Journal of Surgery 2020; 9(02): 5 doi: 10.12677/HJS.2020.92002
28
Mohamed Islam Delma. Besieging the Tumoral Sites: Could It Be an Alternative Therapeutic Strategy in Ductal Pancreatic Adenocarcinoma?Cureus 2020;  doi: 10.7759/cureus.10909